View:
Document
4P6MP6MP6Mfalse--12-31Q2201900015907170.2050.2050.2250.2250.010.01500000000500000000858670449507322385867044950732230.422019-04-152019-07-152019-03-292019-06-280.010.011000000001000000000000P4YP1Y 0001590717 2019-01-01 2019-06-30 0001590717 2019-08-05 0001590717 2018-12-31 0001590717 2019-06-30 0001590717 2019-04-01 2019-06-30 0001590717 2018-04-01 2018-06-30 0001590717 2018-01-01 2018-06-30 0001590717 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001590717 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001590717 2019-01-01 2019-03-31 0001590717 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001590717 us-gaap:CommonStockMember 2018-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001590717 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2019-03-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2019-06-30 0001590717 us-gaap:CommonStockMember 2019-06-30 0001590717 us-gaap:CommonStockMember 2019-03-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2018-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2019-01-01 2019-03-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2019-04-01 2019-06-30 0001590717 2019-03-31 0001590717 2018-01-01 2018-03-31 0001590717 2018-06-30 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2017-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2018-04-01 2018-06-30 0001590717 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2018-01-01 2018-03-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2018-03-31 0001590717 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001590717 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001590717 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001590717 2017-12-31 0001590717 us-gaap:CommonStockMember 2018-03-31 0001590717 2018-03-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001590717 us-gaap:CommonStockMember 2018-06-30 0001590717 us-gaap:CommonStockMember 2017-12-31 0001590717 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001590717 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2018-06-30 0001590717 us-gaap:MortgageReceivablesMember 2019-06-30 0001590717 ctre:IndependentLivingFacilitiesOwnedAndOperatedByCompanyMember 2019-06-30 0001590717 ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember us-gaap:AssetsLeasedToOthersMember 2019-01-01 2019-06-30 0001590717 ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember us-gaap:AssetsLeasedToOthersMember 2019-06-30 0001590717 ctre:SkilledNursingPropertiesMember 2019-01-01 2019-06-30 0001590717 ctre:MultiServiceCampusPropertiesMember 2019-01-01 2019-06-30 0001590717 ctre:AssistedLivingFacilityMember 2019-01-01 2019-06-30 0001590717 ctre:EnsignMasterLeasesMember 2019-06-30 0001590717 ctre:EnsignMasterLeasesMember srt:MaximumMember 2019-06-30 0001590717 ctre:VariousOtherOperatorsMember 2019-06-30 0001590717 ctre:EnsignMasterLeasesMember srt:MinimumMember 2019-06-30 0001590717 ctre:ProvidenceGroupMember us-gaap:MortgageReceivablesMember 2017-10-31 0001590717 ctre:CascadiaDevelopmentLLCMember 2016-07-01 2016-07-31 0001590717 ctre:ProvidenceGroupMember us-gaap:MortgageReceivablesMember 2019-04-01 2019-06-30 0001590717 ctre:CascadiaDevelopmentLLCMember 2019-06-01 2019-06-30 0001590717 ctre:ProvidenceGroupMember us-gaap:MortgageReceivablesMember 2018-01-01 2018-06-30 0001590717 ctre:PreferredEquityInvestmentMember 2019-04-01 2019-06-30 0001590717 ctre:ProvidenceGroupMember us-gaap:MortgageReceivablesMember 2019-01-01 2019-06-30 0001590717 ctre:PreferredEquityInvestmentMember 2018-01-01 2018-06-30 0001590717 ctre:CascadiaDevelopmentLLCMember 2016-09-30 0001590717 ctre:SkilledNursingPropertiesMember 2019-06-01 2019-06-30 0001590717 ctre:CovenantCareMember us-gaap:MortgageReceivablesMember 2019-02-01 2019-02-28 0001590717 ctre:CascadiaDevelopmentLLCMember 2016-09-01 2016-09-30 0001590717 ctre:ProvidenceGroupMember us-gaap:MortgageReceivablesMember 2018-04-01 2018-06-30 0001590717 ctre:CascadiaDevelopmentLLCMember us-gaap:PrimeRateMember 2016-09-01 2016-09-30 0001590717 ctre:CovenantCareMember us-gaap:MortgageReceivablesMember 2019-02-28 0001590717 ctre:CascadiaDevelopmentLLCMember 2016-07-31 0001590717 ctre:CascadiaDevelopmentLLCMember us-gaap:PrimeRateMember 2016-07-01 2016-07-31 0001590717 ctre:PreferredEquityInvestmentMember 2018-04-01 2018-06-30 0001590717 ctre:PreferredEquityInvestmentMember 2019-01-01 2019-06-30 0001590717 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001590717 us-gaap:MortgageReceivablesMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001590717 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2018-12-31 0001590717 us-gaap:MortgageReceivablesMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001590717 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2018-12-31 0001590717 us-gaap:MortgageReceivablesMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001590717 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001590717 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001590717 us-gaap:UnsecuredDebtMember 2019-06-30 0001590717 us-gaap:UnsecuredDebtMember 2018-12-31 0001590717 us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001590717 us-gaap:MortgageReceivablesMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001590717 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2019-06-30 0001590717 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:UnsecuredDebtMember 2019-06-30 0001590717 us-gaap:MortgageReceivablesMember 2018-12-31 0001590717 us-gaap:LineOfCreditMember 2018-12-31 0001590717 us-gaap:LineOfCreditMember 2019-06-30 0001590717 us-gaap:SeniorNotesMember 2018-12-31 0001590717 us-gaap:SeniorNotesMember 2019-06-30 0001590717 ctre:SeniorUnsecuredTermLoanMember 2018-12-31 0001590717 ctre:SeniorUnsecuredTermLoanMember 2019-06-30 0001590717 ctre:FivePointTwoFiveSeniorNotesDue2025Member ctre:SeniorUnsecuredNotesMember 2017-05-10 0001590717 ctre:SwinglineLoanMember 2019-02-08 0001590717 srt:MaximumMember ctre:NewTermLoanFeb2019Member us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-02-08 2019-02-08 0001590717 ctre:RevolvingCreditFacilityAsAmendedMember us-gaap:LineOfCreditMember 2016-02-01 0001590717 ctre:SeniorUnsecuredTermLoanMember us-gaap:LineOfCreditMember 2016-02-01 0001590717 srt:MaximumMember ctre:NewTermLoanFeb2019Member us-gaap:UnsecuredDebtMember us-gaap:BaseRateMember 2019-02-08 2019-02-08 0001590717 ctre:FivePointTwoFiveSeniorNotesDue2025Member ctre:SeniorUnsecuredNotesMember 2017-05-10 2017-05-10 0001590717 srt:MinimumMember ctre:FivePointTwoFiveSeniorNotesDue2025Member us-gaap:DebtInstrumentRedemptionPeriodOneMember ctre:SeniorUnsecuredNotesMember 2017-05-10 2017-05-10 0001590717 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-02-08 2019-02-08 0001590717 ctre:SeniorUnsecuredTermLoanMember us-gaap:LineOfCreditMember 2016-02-01 2016-02-01 0001590717 srt:MinimumMember ctre:NewTermLoanFeb2019Member us-gaap:UnsecuredDebtMember us-gaap:BaseRateMember 2019-02-08 2019-02-08 0001590717 ctre:NewTermLoanFeb2019Member us-gaap:UnsecuredDebtMember 2019-02-08 0001590717 srt:MinimumMember ctre:NewTermLoanFeb2019Member us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-02-08 2019-02-08 0001590717 us-gaap:LetterOfCreditMember 2019-02-08 0001590717 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember 2019-02-08 2019-02-08 0001590717 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember us-gaap:BaseRateMember 2019-02-08 2019-02-08 0001590717 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember us-gaap:BaseRateMember 2019-02-08 2019-02-08 0001590717 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember 2019-02-08 2019-02-08 0001590717 ctre:FivePointTwoFiveSeniorNotesDue2025Member us-gaap:DebtInstrumentRedemptionPeriodOneMember ctre:SeniorUnsecuredNotesMember 2017-05-10 2017-05-10 0001590717 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-02-08 2019-02-08 0001590717 us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember 2019-02-08 0001590717 srt:MaximumMember ctre:FivePointTwoFiveSeniorNotesDue2025Member us-gaap:DebtInstrumentRedemptionPeriodOneMember ctre:SeniorUnsecuredNotesMember 2017-05-10 2017-05-10 0001590717 ctre:RevolvingCreditFacilityAsAmendedMember us-gaap:LineOfCreditMember 2016-02-01 2016-02-01 0001590717 us-gaap:RevolvingCreditFacilityMember ctre:NewRevolvingFacilityMember 2019-02-08 2019-02-08 0001590717 2019-04-15 0001590717 us-gaap:OverAllotmentOptionMember 2019-04-15 2019-04-15 0001590717 2019-04-15 2019-04-15 0001590717 srt:MaximumMember ctre:AtTheMarketOfferingMember 2019-03-04 0001590717 ctre:AtTheMarketOfferingMember 2019-06-30 0001590717 ctre:AtTheMarketOfferingMember 2019-01-01 2019-03-31 0001590717 srt:OfficerMember us-gaap:PerformanceSharesMember 2019-02-01 2019-02-28 0001590717 srt:OfficerMember us-gaap:PerformanceSharesMember 2019-02-28 0001590717 ctre:EnsignEmployeesMember 2014-06-01 2014-06-01 0001590717 srt:OfficerMember us-gaap:RestrictedStockMember 2019-02-28 0001590717 srt:OfficerMember us-gaap:RestrictedStockMember 2019-02-01 2019-02-28 0001590717 srt:DirectorMember us-gaap:RestrictedStockMember 2019-05-01 2019-05-31 0001590717 ctre:EnsignEmployeesMember us-gaap:RestrictedStockMember 2019-06-30 0001590717 ctre:EnsignEmployeesMember us-gaap:RestrictedStockMember 2014-06-01 2014-06-01 0001590717 srt:MaximumMember srt:OfficerMember us-gaap:PerformanceSharesMember 2019-02-01 2019-02-28 0001590717 srt:MinimumMember srt:OfficerMember us-gaap:PerformanceSharesMember 2019-02-01 2019-02-28 0001590717 ctre:EnsignMember ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember us-gaap:AssetsLeasedToOthersMember 2019-06-30 0001590717 ctre:EnsignMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001590717 ctre:EnsignMember ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember us-gaap:AssetsLeasedToOthersMember 2019-01-01 2019-06-30 0001590717 ctre:EnsignMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001590717 ctre:EnsignMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001590717 ctre:EnsignMember 2019-01-01 2019-06-30 0001590717 ctre:EnsignMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-01 2018-06-30 0001590717 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-04-01 2019-06-30 0001590717 srt:ConsolidationEliminationsMember 2019-04-01 2019-06-30 0001590717 srt:SubsidiaryIssuerMember srt:ReportableLegalEntitiesMember 2019-04-01 2019-06-30 0001590717 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-04-01 2019-06-30 0001590717 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-06-30 0001590717 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-06-30 0001590717 srt:ConsolidationEliminationsMember 2018-01-01 2018-06-30 0001590717 srt:SubsidiaryIssuerMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-06-30 0001590717 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2017-12-31 0001590717 srt:ConsolidationEliminationsMember 2017-12-31 0001590717 srt:ConsolidationEliminationsMember 2018-06-30 0001590717 srt:SubsidiaryIssuerMember srt:ReportableLegalEntitiesMember 2017-12-31 0001590717 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2017-12-31 0001590717 srt:SubsidiaryIssuerMember srt:ReportableLegalEntitiesMember 2018-06-30 0001590717 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-06-30 0001590717 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-06-30 0001590717 srt:ConsolidationEliminationsMember 2018-12-31 0001590717 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-12-31 0001590717 srt:SubsidiaryIssuerMember srt:ReportableLegalEntitiesMember 2018-12-31 0001590717 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0001590717 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-06-30 0001590717 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-06-30 0001590717 srt:ConsolidationEliminationsMember 2019-01-01 2019-06-30 0001590717 srt:SubsidiaryIssuerMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-06-30 0001590717 srt:SubsidiaryIssuerMember srt:ReportableLegalEntitiesMember 2019-06-30 0001590717 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-06-30 0001590717 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-06-30 0001590717 srt:ConsolidationEliminationsMember 2019-06-30 0001590717 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-04-01 2018-06-30 0001590717 srt:SubsidiaryIssuerMember srt:ReportableLegalEntitiesMember 2018-04-01 2018-06-30 0001590717 srt:ConsolidationEliminationsMember 2018-04-01 2018-06-30 0001590717 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-04-01 2018-06-30 0001590717 srt:ScenarioForecastMember us-gaap:TradeAccountsReceivableMember 2019-07-01 2019-09-30 0001590717 ctre:TrilliumHealthcareGroupOriginalLeaseMember stpr:GA us-gaap:SubsequentEventMember 2019-07-15 0001590717 ctre:TrilliumHealthcareGroupNewLeaseMember stpr:IA us-gaap:SubsequentEventMember 2019-07-15 0001590717 ctre:TrilliumHealthcareGroupOriginalLeaseMember stpr:OH us-gaap:SubsequentEventMember 2019-07-15 0001590717 ctre:OhioSkilledNursingOperatorMember stpr:OH srt:ScenarioForecastMember 2019-09-01 0001590717 srt:ScenarioForecastMember 2019-09-01 2019-09-01 0001590717 ctre:TrilliumHealthcareGroupNewLeaseMember stpr:GA us-gaap:SubsequentEventMember 2019-07-15 0001590717 ctre:TrilliumHealthcareGroupOriginalLeaseMember stpr:IA us-gaap:SubsequentEventMember 2019-07-15 ctre:investment iso4217:USD ctre:extension_option ctre:property ctre:state xbrli:shares ctre:unit ctre:facility iso4217:USD xbrli:shares ctre:lease ctre:loan ctre:installment ctre:bed xbrli:pure
Table of Contents

 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 FORM 10-Q
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2019
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     

Commission File Number: 001-36181

 
CareTrust REIT, Inc.
(Exact name of registrant as specified in its charter)
 
Maryland
 
46-3999490
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
 
 
 
 
 
905 Calle Amanecer
,
Suite 300
,
San Clemente
,
CA
 
92673
(Address of principal executive offices)
 
(Zip Code)
(949) 542-3130
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
CTRE
The Nasdaq Stock Market LLC
 
 
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      Yes      No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).      Yes      No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer
 
Accelerated filer
Non-accelerated filer
 
Smaller reporting company
 
 
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      Yes      No
As of August 5, 2019, there were 95,557,271 shares of common stock outstanding.





Table of Contents

INDEX
 
PART I—FINANCIAL INFORMATION
Item 1.
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
 
 
PART II—OTHER INFORMATION
 
 
 
Item 1.
Item 1A.
Item 2.
Item 6.
 





Table of Contents


PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
CARETRUST REIT, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
(Unaudited)
 
 
June 30, 2019
 
December 31, 2018
Assets:
 
 
 
Real estate investments, net
$
1,482,040

 
$
1,216,237

Other real estate investments, net
26,725

 
18,045

Cash and cash equivalents
2,629

 
36,792

Accounts and other receivables, net
9,705

 
11,387

Prepaid expenses and other assets
6,947

 
8,668

Deferred financing costs, net
3,513

 
633

Total assets
$
1,531,559

 
$
1,291,762

Liabilities and Equity:
 
 
 
Senior unsecured notes payable, net
$
295,532

 
$
295,153

Senior unsecured term loan, net
198,608

 
99,612

Unsecured revolving credit facility
45,000

 
95,000

Accounts payable and accrued liabilities
12,665

 
15,967

Dividends payable
21,617

 
17,783

Total liabilities
573,422

 
523,515

Commitments and contingencies (Note 10)

 

Equity:
 
 
 
Preferred stock, $0.01 par value; 100,000,000 shares authorized, no shares issued and outstanding as of June 30, 2019 and December 31, 2018

 

Common stock, $0.01 par value; 500,000,000 shares authorized, 95,073,223 and 85,867,044 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively
951

 
859

Additional paid-in capital
1,161,144

 
965,578

Cumulative distributions in excess of earnings
(203,958
)
 
(198,190
)
Total equity
958,137

 
768,247

Total liabilities and equity
$
1,531,559

 
$
1,291,762

See accompanying notes to condensed consolidated financial statements.


1

Table of Contents

CARETRUST REIT, INC.
CONDENSED CONSOLIDATED INCOME STATEMENTS
(in thousands, except per share amounts)
(Unaudited)
 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Revenues:
 
 
 
 
 
 
 
Rental income
$
44,123

 
$
34,708

 
$
82,470

 
$
68,524

Tenant reimbursements

 
3,016

 

 
5,984

Independent living facilities
887

 
845

 
1,747

 
1,644

Interest and other income
1,191

 
400

 
1,642

 
918

Total revenues
46,201

 
38,969

 
85,859

 
77,070

Expenses:
 
 
 
 
 
 
 
Depreciation and amortization
13,437

 
11,299

 
25,339

 
22,876

Interest expense
7,285

 
7,285

 
14,145

 
14,377

Property taxes
456

 
3,016

 
1,282

 
5,984

Independent living facilities
719

 
744

 
1,426

 
1,460

General and administrative
4,606

 
3,358

 
7,916

 
6,550

Total expenses
26,503

 
25,702

 
50,108

 
51,247

Other income:
 
 
 
 
 
 
 
Gain on sale of real estate

 

 

 
2,051

Net income
$
19,698

 
$
13,267

 
$
35,751

 
$
27,874

Earnings per common share:
 
 
 
 
 
 
 
Basic
$
0.21

 
$
0.17

 
$
0.39

 
$
0.36

Diluted
$
0.21

 
$
0.17

 
$
0.39

 
$
0.36

Weighted-average number of common shares:
 
 
 
 
 
 
 
Basic
94,036

 
76,374

 
91,039

 
75,941

Diluted
94,036

 
76,374

 
91,039

 
75,941

See accompanying notes to condensed consolidated financial statements.


2

Table of Contents

CARETRUST REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(in thousands, except share and per share amounts)
(Unaudited)


 
Common Stock
 
Additional
Paid-in
Capital
 
Cumulative
Distributions in Excess of Earnings
 
Total
Equity
Shares
 
Amount
 
Balance at January 1, 2019
85,867,044

 
$
859

 
$
965,578

 
$
(198,190
)
 
$
768,247

Issuance of common stock, net
2,459,000

 
24

 
47,219

 

 
47,243

Vesting of restricted common stock, net of shares withheld for employee taxes
72,229

 
1

 
(1,496
)
 

 
(1,495
)
Amortization of stock-based compensation

 

 
994

 

 
994

Common dividends ($0.225 per share)

 

 

 
(20,011
)
 
(20,011
)
Net income

 

 

 
16,053

 
16,053

Balance at March 31, 2019
88,398,273

 
$
884

 
$
1,012,295

 
$
(202,148
)
 
$
811,031

Issuance of common stock, net
6,641,250

 
67

 
148,731

 

 
148,798

Vesting of restricted common stock, net of shares withheld for employee taxes
33,700

 

 
(1,029
)
 

 
(1,029
)
Amortization of stock-based compensation

 

 
1,147

 

 
1,147

Common dividends ($0.225 per share)

 

 

 
(21,508
)
 
(21,508
)
Net income

 

 

 
19,698

 
19,698

Balance at June 30, 2019
95,073,223

 
$
951

 
$
1,161,144

 
$
(203,958
)
 
$
958,137

































See accompanying notes to condensed consolidated financial statements.

3

Table of Contents


CARETRUST REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(in thousands, except share and per share amounts)
(Unaudited)

 
Common Stock
 
Additional
Paid-in
Capital
 
Cumulative
Distributions in Excess of Earnings
 
Total
Equity
Shares
 
Amount
 
Balance at January 1, 2018
75,478,202

 
$
755

 
$
783,237

 
$
(189,375
)
 
$
594,617

Issuance of common stock, net

 

 
(27
)
 

 
(27
)
Vesting of restricted common stock, net of shares withheld for employee taxes
43,844

 

 
(605
)
 

 
(605
)
Amortization of stock-based compensation

 

 
904

 

 
904

Common dividends ($0.205 per share)

 

 

 
(15,608
)
 
(15,608
)
Net income

 

 

 
14,607

 
14,607

Balance as of March 31, 2018
75,522,046

 
$
755

 
$
783,509

 
$
(190,376
)
 
$
593,888

Issuance of common stock, net
2,988,813

 
30

 
47,537

 

 
47,567

Vesting of restricted common stock, net of shares withheld for employee taxes
39,828

 

 
(684
)
 

 
(684
)
Amortization of stock-based compensation

 

 
924

 

 
924

Common dividends ($0.205 per share)

 

 

 
(16,224
)
 
(16,224
)
Net income

 

 

 
13,267

 
13,267

Balance at June 30, 2018
78,550,687

 
$
785

 
$
831,286

 
$
(193,333
)
 
$
638,738


















See accompanying notes to condensed consolidated financial statements.

4

Table of Contents

CARETRUST REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)

 
For the Six Months Ended June 30,
 
2019
 
2018
Cash flows from operating activities:
 
 
 
Net income
$
35,751

 
$
27,874

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization (including below-market ground leases)
25,354

 
22,885

Amortization of deferred financing costs
1,028

 
969

Amortization of stock-based compensation
2,141

 
1,828

Straight-line rental income
(937
)
 
(933
)
Noncash interest income
(21
)
 
(217
)
Gain on sale of real estate

 
(2,051
)
Interest income distribution from other real estate investment
463

 

Change in operating assets and liabilities:
 
 
 
Accounts and other receivables, net
(2,091
)
 
(2,837
)
Prepaid expenses and other assets
(185
)
 
(462
)
Accounts payable and accrued liabilities
235

 
(4,940
)
Net cash provided by operating activities
61,738

 
42,116

Cash flows from investing activities:
 
 
 
Acquisitions of real estate, net of deposits applied
(285,946
)
 
(47,310
)
Improvements to real estate
(68
)
 
(506
)
Purchases of equipment, furniture and fixtures
(2,613
)
 
(702
)
Investment in real estate mortgage and other loans receivable
(11,389
)
 
(1,390
)
Principal payments received on real estate mortgage and other loans receivable
482

 
58

Repayment of other real estate investment
2,204

 

Escrow deposits for acquisitions of real estate

 
(2,250
)
Net proceeds from the sale of real estate
131

 
13,004

Net cash used in investing activities
(297,199
)
 
(39,096
)
Cash flows from financing activities:
 
 
 
Proceeds from the issuance of common stock, net
196,041

 
47,547

Proceeds from the issuance of senior unsecured term loan
200,000

 

Borrowings under unsecured revolving credit facility
195,000

 
60,000

Payments on unsecured revolving credit facility
(245,000
)
 
(75,000
)
Payments on senior unsecured term loan
(100,000
)
 

Payments of deferred financing costs
(4,534
)
 

Net-settle adjustment on restricted stock
(2,524
)
 
(1,288
)
Dividends paid on common stock
(37,685
)
 
(29,628
)
Net cash provided by financing activities
201,298

 
1,631

Net (decrease) increase in cash and cash equivalents
(34,163
)
 
4,651

Cash and cash equivalents, beginning of period
36,792

 
6,909

Cash and cash equivalents, end of period
$
2,629

 
$
11,560

Supplemental disclosures of cash flow information:
 
 
 
Interest paid
$
12,963

 
$
13,411

Supplemental schedule of noncash investing and financing activities:
 
 
 
Increase in dividends payable
$
3,834

 
$
2,205

Right-of-use asset obtained in exchange for new operating lease obligation
$
1,010

 
$

Transfer of pre-acquisition costs to acquired assets
$
242

 
$
60

Increase in pre-acquisition costs payable
$
86

 
$
35

See accompanying notes to condensed consolidated financial statements.

5

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)



1. ORGANIZATION
Description of Business—CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of June 30, 2019, the Company owned and leased to independent operators, including The Ensign Group, Inc. (“Ensign”), 213 skilled nursing, multi-service campuses, assisted living and independent living facilities consisting of 21,686 operational beds and units located in Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New Mexico, North Carolina, North Dakota, Ohio, Oregon, South Dakota, Texas, Utah, Virginia, Washington, West Virginia and Wisconsin. The Company also owns and operates three independent living facilities which have a total of 264 units located in Texas and Utah. As of June 30, 2019, the Company also had other real estate investments consisting of one preferred equity investment of $3.1 million and two mortgage loans receivable of $23.6 million.

 
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation—The accompanying condensed consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company and its consolidated subsidiaries consisting of (i) the net-leased skilled nursing, multi-service campuses, assisted living and independent living facilities, (ii) the operations of the three independent living facilities that the Company owns and operates; and (iii) the preferred equity investment and the mortgage loans receivable.
The accompanying condensed consolidated financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, the condensed consolidated financial statements do not include all of the disclosures required by GAAP for a complete set of annual audited financial statements. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018. In the opinion of management, all adjustments which are of a normal and recurring nature and considered necessary for a fair presentation of the results of the interim periods presented have been included. The results of operations for the interim periods are not necessarily indicative of results for the full year. All intercompany transactions and account balances within the Company have been eliminated.

Recent Accounting Standards Adopted by the Company—On January 1, 2019, the Company adopted Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), (“ASU 2016-02”) that sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a lease agreement (i.e., lessees and lessors). Upon adoption of ASU 2016-02 on January 1, 2019, the Company elected the following practical expedients provided by ASU No. 2018-11, Leases - Targeted Improvements, and ASU No. 2018-20, Narrow Scope Improvements for Lessors (together with ASU 2016-02, the “new lease ASUs”):

Package of practical expedients – provides that the Company is not required to reevaluate its existing or expired leases as of January 1, 2019, under the new lease ASUs.
Optional transition method practical expedient – requires the Company to apply the new lease ASUs prospectively from the adoption date of January 1, 2019.
Single component practical expedient – requires the Company to account for lease and non-lease components associated with that lease as a single component under the new lease ASUs, if certain criteria are met.
Short-term leases practical expedient – for the Company’s operating leases with a term of less than 12 months in which it is the lessee, this expedient requires the Company not to record on its balance sheet related lease liabilities and right-of-use assets.
Overview related to both lessee and lessor accounting—The new lease ASUs set new criteria for determining the classification of finance leases for lessees and sales-type leases for lessors. The criteria to determine whether a lease should be accounted for as a finance (sales-type) lease include the following: (i) ownership is transferred from lessor to lessee by the end of the lease term, (ii) an option to purchase is reasonably certain to be exercised, (iii) the lease term is for the major part of the underlying asset’s remaining economic life, (iv) the present value of lease payments equals or exceeds substantially all of the fair value of the underlying asset, and (v) the underlying asset is specialized and is expected to have no alternative use at the end of the lease term. If any of these criteria is met, a lease is classified as a finance lease by the lessee and as a sales-type lease

6

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


by the lessor. If none of the criteria are met, a lease is classified as an operating lease by the lessee, but may still qualify as a direct financing lease or an operating lease for the lessor. The existence of a residual value guarantee from an unrelated third party other than the lessee may qualify the lease as a direct financing lease by the lessor. Otherwise, the lease is classified as an operating lease by the lessor.
The election of the package of practical expedients discussed above and the optional transition method allowed the Company not to reassess:

Whether any expired or existing contracts as of January 1, 2019 were leases or contained leases.
This practical expedient is primarily applicable to entities that have contracts containing embedded leases. As of January 1, 2019, the Company had no such contracts; therefore, this practical expedient had no effect on the Company.
The lease classification for any leases expired or existing as of January 1, 2019.
The election of the package of practical expedients provides that the Company is not required to reassess the classification of its leases existing as of January 1, 2019. This means that all of the Company’s leases that were classified as operating leases in accordance with the lease accounting standards in effect prior to January 1, 2019 continue to be classified as operating leases after adoption of the new lease ASUs.
The Company applied the package of practical expedients consistently to all leases (i.e., regardless of whether the Company was the lessee or a lessor) that commenced before January 1, 2019. The election of this package permits the Company to “run off” its leases that commenced before January 1, 2019, for the remainder of their lease terms and to apply the new lease ASUs to leases commencing or modified after January 1, 2019.
Lessor Accounting—Under the new lease ASUs, each lease agreement is evaluated to identify the lease and non-lease components at lease inception. The total consideration in the lease agreement is allocated to the lease and non-lease components based on their relative stand-alone selling prices. The new lease ASUs govern the recognition of revenue for lease components, and revenue related to non-lease components is subject to the new revenue recognition standard. Tenant recoveries for utilities, repairs and maintenance, and common area expenses are considered non-lease components. The Company generates revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. As such, the Company has concluded its leases do not contain material non-lease components. Tenant reimbursements related to property taxes and insurance are neither lease nor non-lease components under the new lease ASUs. If a lessee makes payments for taxes and insurance directly to a third party on behalf of a lessor, lessors are required to exclude them from variable payments and from recognition in the lessors’ income statements. Otherwise, tenant recoveries for taxes and insurance are classified as additional rental income recognized by the lessor on a gross basis in its income statements.
On January 1, 2019, the Company elected the single component practical expedient, which allows a lessor, by class of underlying asset, not to allocate the total consideration to the lease and non-lease components based on their relative stand-alone selling prices. This single component practical expedient requires the Company to account for the lease component and non-lease component(s) associated with that lease as a single component if (i) the timing and pattern of transfer of the lease component and the non-lease component(s) associated with it are the same and (ii) the lease component would be classified as an operating lease if it were accounted for separately. If the Company determines that the lease component is the predominant component, the Company accounts for the single component as an operating lease in accordance with the new lease ASUs. Conversely, the Company is required to account for the combined component under the new revenue recognition standard if the Company determines that the non-lease component is the predominant component. As a result of this assessment, rental revenues and tenant recoveries from the lease of real estate assets that qualify for this expedient are accounted for as a single component under the new lease ASUs, with tenant recoveries primarily as variable consideration. Tenant recoveries that do not qualify for the single component practical expedient and are considered non-lease components are accounted for under the revenue recognition standard. The components of the Company’s operating leases qualify for the single component presentation.
For the three and six months ended June 30, 2018, the Company recognized tenant recoveries for real estate taxes of $3.0 million and $6.0 million, respectively, which were classified as tenant reimbursements on the Company’s condensed consolidated income statements. Prior to the adoption of Accounting Standards Codification (“ASC”) 842, the Company recognized tenant recoveries as tenant reimbursement revenues regardless of whether the third party was paid by the lessor or lessee. Effective January 1, 2019, such tenant recoveries are recognized to the extent that the Company pays the third party

7

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


directly and classified as rental income on the Company’s condensed consolidated income statements. Due to the application of the new lease ASUs, the Company recognized, on a gross basis, real estate taxes of $0.5 million and $1.3 million, respectively, for the three and six months ended June 30, 2019.
Under the new lease ASUs, the Company’s assessment of collectability of its tenant receivables includes a binary assessment of whether or not the amounts due under a tenant’s lease agreement are probable of collection. For such amounts that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term. For such amounts that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectability determination. Such write-offs are recorded as increases or decreases through rental income on the Company’s condensed consolidated income statements. For the three and six months ended June 30, 2019, the Company did not recognize any adjustments to rental income related to recognized rental income in prior periods.
Lessee Accounting—Under the new lease ASUs, lessees are required to apply a dual approach by classifying leases as either finance or operating leases based on the principle of whether the lease is effectively a financed purchase of the leased asset by the lessee. This classification will determine whether the lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, which corresponds to a similar evaluation performed by lessors. In addition to this classification, a lessee is also required to recognize a right-of-use asset and a lease liability for all leases regardless of their classification, whereas a lessor is not required to recognize a right-of-use asset and a lease liability for any operating leases.
As of June 30, 2019, the Company’s lease liability related to its ground lease arrangements for which it is the lessee totaled approximately $1.0 million with a weighted average remaining lease term of 73 years. While these ground leases are subject to the new lease ASUs effective January 1, 2019, the lease liability and corresponding right-of-use asset and lease expense do not have a material effect on the Company’s condensed consolidated financial statements.
The Company has not recognized a right of use lease asset and/or lease liability for leases with a term of 12 months or less and without an option to purchase the underlying asset.
Estimates and Assumptions—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions. 
 
Real Estate Acquisition Valuation— In accordance with ASC 805, Business Combinations, acquisitions that are income-producing real estate are recorded as a business combination. If the acquisition does not meet the definition of a business, acquisitions are recorded as an asset acquisition. The assets acquired and liabilities assumed are measured at their acquisition date fair values for a business combination and at relative fair values for an asset acquisition. For transactions that are business combinations, acquisition costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. For transactions that are asset acquisitions, acquisition costs are capitalized as incurred. The Company’s real estate acquisitions generally are classified as asset acquisitions.
In addition, for such asset acquisitions, no goodwill is recognized and third party transaction costs are capitalized. The Company allocates the acquisition costs to the tangible assets, identifiable intangible assets/liabilities and assumed liabilities on a relative fair value basis. The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate such market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant.

As part of the Company’s real estate acquisitions, the Company may commit to provide contingent payments to a seller or lessee (e.g., an earn-out payable upon the applicable property achieving certain financial metrics). Typically, when the contingent payments are funded, cash rent is increased by the amount funded multiplied by a rate stipulated in the agreement.

8

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


Generally, if the contingent payment is an earn-out provided to the seller, the payment is capitalized to the property’s basis. If the contingent payment is an earn-out provided to the lessee, the payment is recorded as a lease incentive and is amortized as a yield adjustment over the life of the lease.
Impairment of Long-Lived Assets—At each reporting period, management evaluates the Company’s real estate investments for impairment indicators, including the evaluation of the useful lives of the Company’s assets. Management also assesses the carrying value of the Company’s real estate investments whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.
If the Company decides to sell real estate properties, it evaluates the recoverability of the carrying amounts of the assets. If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell.
In the event of impairment, the fair value of the real estate investment is determined by market research, which includes valuing the property in its current use as well as other alternative uses, and involves significant judgment. Management’s estimates of cash flows and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.
Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions. 
Recent Accounting Pronouncements—In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Subtopic 326) (“ASU 2016-13”) that changes the impairment model for most financial instruments by requiring companies to recognize an allowance for expected losses, rather than incurred losses as required currently by the other-than-temporary impairment model. ASU 2016-13 will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases, and off-balance-sheet credit exposures (e.g., loan commitments). In November 2018, the FASB released ASU No. 2018-19, Codification Improvements to Topic 326 Financial Instruments - Credit Losses (“ASU 2018-19”.) ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of ASU 2016-13. Instead, impairment of receivables arising from operating leases should be accounted for under Subtopic 842-30 “Leases - Lessor.” ASU 2016-13 is effective for reporting periods beginning after December 15, 2019, with early adoption permitted, and will be applied as a cumulative adjustment to retained earnings as of the effective date. The Company is currently assessing the potential effect the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.




9

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


3. REAL ESTATE INVESTMENTS, NET
The following table summarizes the Company’s investment in owned properties as of June 30, 2019 and December 31, 2018 (dollars in thousands):
 
 
June 30, 2019
 
December 31, 2018
Land
$
197,510

 
$
166,948

Buildings and improvements
1,453,944

 
1,201,209

Integral equipment, furniture and fixtures
95,476

 
87,623

Identified intangible assets
1,400

 
2,382

Real estate investments
1,748,330

 
1,458,162

Accumulated depreciation and amortization
(266,290
)
 
(241,925
)
Real estate investments, net
$
1,482,040

 
$
1,216,237


As of June 30, 2019, 93 of the Company’s 216 facilities were leased to subsidiaries of Ensign under eight master leases (the “Ensign Master Leases”) which commenced on June 1, 2014. The obligations under the Ensign Master Leases are guaranteed by Ensign. A default by any subsidiary of Ensign with regard to any facility leased pursuant to an Ensign Master Lease will result in a default under all of the Ensign Master Leases. As of June 30, 2019, annualized rental revenues from the Ensign Master Leases were $61.0 million and are escalated annually by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the Ensign Master Leases are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs).
As of June 30, 2019, 120 of the Company’s 216 facilities were leased to various other operators under triple-net leases. All of these leases contain annual escalators based on CPI, some of which are subject to a cap, or fixed rent escalators.
The Company’s three remaining properties as of June 30, 2019 are the independent living facilities that the Company owns and operates.
As of June 30, 2019, the Company’s total future minimum rental revenues for all of its tenants, excluding operating expense reimbursements, were (dollars in thousands): 
Year
Amount
2019 (six months)
$
86,806

2020
173,965

2021
174,423

2022
174,899

2023
175,232

2024
175,492

Thereafter
1,132,935

 
$
2,093,752








10

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


As of December 31, 2018, the Company’s total future minimum rental revenues for all of its tenants, excluding operating expense reimbursements, were (dollars in thousands):
Year
Amount
2019
$
146,010

2020
146,560

2021
147,132

2022
147,719

2023
148,169

Thereafter
1,055,012

 
$
1,790,602



Recent Real Estate Acquisitions

The following table summarizes the Company’s acquisitions for the six months ended June 30, 2019 (dollars in thousands):

Type of Property
Purchase Price(1)
 
Initial Annual Cash Rent(2)
 
Number of Properties
 
Number of Beds/Units(3)
Skilled nursing
$
246,099

 
$
22,129

 
16

 
2,029

Multi-service campuses
45,176

 
4,088

 
3

 
542

Assisted living

 

 

 

Total
$
291,275

 
$
26,217

 
19

 
2,571

    
(1) Purchase price includes capitalized acquisition costs.
(2) Initial annual cash rent excludes ground lease income.
(3) The number of beds/units includes operating beds at acquisition date.


4. OTHER REAL ESTATE INVESTMENTS

Preferred Equity Investments—In July 2016, the Company completed a $2.2 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yielded a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Nampa, Idaho. In connection with its investment, the Company held an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the fourth quarter 2017 and began lease-up during the first quarter of 2018. In June 2019, the Company purchased the skilled nursing facility for approximately $16.2 million, inclusive of transaction costs. The Company paid $12.9 million after receiving back its initial investment of $2.2 million and cumulative contractual preferred return through June 18, 2019, the acquisition date, of $1.1 million, of which $0.6 million was recognized as interest income during the three months ended June 30, 2019.

In September 2016, the Company completed a $2.3 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yields a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Boise, Idaho. In connection with its investment, the Company holds an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the first quarter 2018 and began lease-up in the second quarter of 2018.

During the three months ended June 30, 2019, the Company recognized $0.6 million in interest income from its preferred equity investments, including $0.5 million for unrecognized preferred return related to prior periods. During the six months ended June 30, 2019, the Company recognized $0.6 million in interest income from its preferred equity investments, including $0.4 million for unrecognized preferred return related to prior periods. During the three and six months ended June

11

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


30, 2018, the Company recognized $0.1 million and $0.2 million, respectively, in interest income from its preferred equity investments.

Performing Mortgage Loans Receivable—In October 2017, the Company provided an affiliate of Providence Group, Inc. (“Providence”) a mortgage loan secured by a skilled nursing facility for approximately $12.5 million inclusive of transaction costs, which bears a fixed interest rate of 9%. The mortgage loan requires Providence to make monthly principal and interest payments, is set to mature on October 26, 2020 and has an option to be prepaid before the maturity date.

In February 2019, the Company provided affiliates of Covenant Care a mortgage loan secured by first mortgages on five skilled nursing facilities for approximately $11.4 million, at an annual interest rate of 9%. The loan requires monthly interest payments, is set to mature on February 11, 2020, and includes twosix-month extension options.

During the three and six months ended June 30, 2019, the Company recognized $0.5 million and $1.0 million, respectively, of interest income related to the mortgage loans. During the three and six months ended June 30, 2018, the Company recognized $0.3 million and $0.6 million, respectively, of interest income related to the mortgage loans.



5. FAIR VALUE MEASUREMENTS
Financial Instruments: Considerable judgment is necessary to estimate the fair value of financial instruments. The estimates of fair value presented herein are not necessarily indicative of the amounts that could be realized upon disposition of the financial instruments. A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of June 30, 2019 and December 31, 2018 using Level 2 inputs for the Notes (as defined in Note 6, Debt, below), and Level 3 inputs, for all other financial instruments, is as follows (dollars in thousands):
 
 
 
June 30, 2019
 
December 31, 2018
 
Face
Value
 
Carrying
Amount
 
Fair
Value
 
Face
Value
 
Carrying
Amount
 
Fair
Value
Financial assets:
 
 
 
 
 
 
 
 
 
 
 
Preferred equity investments
$
2,327

 
$
3,079

 
$
3,415

 
$
4,531

 
$
5,746

 
$
6,246

Mortgage loans receivable
23,701

 
23,646

 
23,701

 
12,375

 
12,299

 
12,375

Financial liabilities:
 
 
 
 
 
 
 
 
 
 
 
Senior unsecured notes payable
$
300,000

 
$
295,532

 
$
311,625

 
$
300,000

 
$
295,153

 
$
289,500


Cash and cash equivalents, accounts and other receivables, other loans receivable, and accounts payable and accrued liabilities: These balances approximate their fair values due to the short-term nature of these instruments.
Preferred equity investments: The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements.
Mortgage loans receivable: The fair values of the mortgage loans receivable were estimated using an internal valuation model that considered the expected future cash flows of the investments, the underlying collateral value, market interest rates and other credit enhancements.
Senior unsecured notes payable: The fair value of the Notes was determined using third-party quotes derived from orderly trades.
Unsecured revolving credit facility and senior unsecured term loan: The fair values approximate their carrying values as the interest rates are variable and approximate prevailing market interest rates for similar debt arrangements.
 


12

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)



6. DEBT
The following table summarizes the balance of the Company’s indebtedness as of June 30, 2019 and December 31, 2018 (dollars in thousands):
 
June 30, 2019
 
December 31, 2018
 
Principal Amount
Deferred Loan Fees
Carrying Value
 
Principal Amount
Deferred Loan Fees
Carrying Value
Senior unsecured notes payable
$
300,000

$
(4,468
)
$
295,532

 
$
300,000

$
(4,847
)
$
295,153

Senior unsecured term loan
200,000

(1,392
)
198,608

 
100,000

(388
)
99,612

Unsecured revolving credit facility
45,000


45,000

 
95,000


95,000

 
$
545,000

$
(5,860
)
$
539,140

 
$
495,000

$
(5,235
)
$
489,765


Senior Unsecured Notes Payable
On May 10, 2017, the Company’s wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed an underwritten public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “Notes”). The Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. The Notes mature on June 1, 2025 and bear interest at a rate of 5.25% per year. Interest on the Notes is payable on June 1 and December 1 of each year.
The Issuers may redeem the Notes any time before June 1, 2020 at a redemption price of 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest on the Notes, if any, to, but not including, the redemption date, plus a “make-whole” premium described in the indenture governing the Notes and, at any time on or after June 1, 2020, at the redemption prices set forth in the indenture. At any time on or before June 1, 2020, up to 40% of the aggregate principal amount of the Notes may be redeemed with the net proceeds of certain equity offerings if at least 60% of the originally issued aggregate principal amount of the Notes remains outstanding. In such case, the redemption price will be equal to 105.25% of the aggregate principal amount of the Notes to be redeemed plus accrued and unpaid interest, if any, to, but not including, the redemption date. If certain changes of control of the Company occur, holders of the Notes will have the right to require the Issuers to repurchase their Notes at 101% of the principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.
The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by the Company and certain of the Company’s wholly owned existing and, subject to certain exceptions, future material subsidiaries (other than the Issuers); provided, however, that such guarantees are subject to automatic release under certain customary circumstances, as described in Note 12, Summarized Condensed Consolidating Information.
The indenture contains customary covenants such as limiting the ability of the Company and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture also requires the Company and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture also contains customary events of default.
As of June 30, 2019, the Company was in compliance with all applicable financial covenants under the indenture.

Unsecured Revolving Credit Facility and Term Loan
On August 5, 2015, the Company, CareTrust GP, LLC, the Operating Partnership, as the borrower, and certain of its wholly owned subsidiaries entered into a credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Prior Credit Agreement”). As later amended on

13

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


February 1, 2016, the Prior Credit Agreement provided the following: (i) a $400.0 million unsecured asset based revolving credit facility (the “Prior Revolving Facility”), (ii) a $100.0 million non-amortizing unsecured term loan (the “Prior Term Loan” and, together with the Prior Revolving Facility, the “Prior Credit Facility”), and (iii) a $250.0 million uncommitted incremental facility. The Prior Revolving Facility was scheduled to mature on August 5, 2019, subject to two, six-month extension options. The Prior Term Loan was scheduled to mature on February 1, 2023 and could be prepaid at any time subject to a 2% premium in the first year after issuance and a 1% premium in the second year after issuance.
On February 8, 2019, the Operating Partnership, as the borrower, the Company, as guarantor, CareTrust GP, LLC, and certain of the Operating Partnership’s wholly owned subsidiaries entered into an amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Amended Credit Agreement”). The Amended Credit Agreement, which amended and restated the Prior Credit Agreement, provides for: (i) an unsecured revolving credit facility (the “Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) an unsecured term loan credit facility (the “Term Loan” and, together with the Revolving Facility, the “Amended Credit Facility”) in an aggregate principal amount of $200.0 million. Borrowing availability under the Revolving Facility is subject to no default or event of default under the Amended Credit Agreement having occurred at the time of borrowing. The proceeds of the Term Loan were used, in part, to repay in full all outstanding borrowings under the Prior Term Loan and Prior Revolving Facility under the Prior Credit Agreement. Future borrowings under the Amended Credit Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
The interest rates applicable to loans under the Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.10% to 0.55% per annum or LIBOR plus a margin ranging from 1.10% to 1.55% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). The interest rates applicable to loans under the Term Loan are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.50% to 1.20% per annum or LIBOR plus a margin ranging from 1.50% to 2.20% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). In addition, the Operating Partnership will pay a facility fee on the revolving commitments under the Revolving Facility ranging from 0.15% to 0.35% per annum, based on the debt to asset value ratio of the Company and its consolidated subsidiaries (unless the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt and the Operating Partnership elects to decrease the applicable margin as described above, in which case the Operating Partnership will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based on the credit ratings of the Company’s senior long-term unsecured debt). As of June 30, 2019, the Operating Partnership had $200.0 million outstanding under the Term Loan and $45.0 million outstanding under the Revolving Facility.
The Revolving Facility has a maturity date of February 8, 2023, and includes, at the sole discretion of the Operating Partnership, two, six-month extension options. The Term Loan has a maturity date of February 8, 2026.
The Amended Credit Facility is guaranteed, jointly and severally, by the Company and its wholly owned subsidiaries that are party to the Amended Credit Agreement (other than the Operating Partnership). The Amended Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend organizational documents and pay certain dividends and other restricted payments. The Amended Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio, a maximum secured recourse debt to asset value ratio, a maximum unsecured debt to unencumbered properties asset value ratio, a minimum unsecured interest coverage ratio and a minimum rent coverage ratio. The Amended Credit Agreement also contains certain customary events of default, including the failure to make timely payments under the Amended Credit Facility or other material indebtedness, the failure to satisfy certain covenants (including the financial maintenance covenants), the occurrence of change of control and specified events of bankruptcy and insolvency.
As of June 30, 2019, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.

14

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)



7. EQUITY
Common Stock
Public Offering of Common Stock—On April 15, 2019, the Company completed an underwritten public offering of 6,641,250 shares of its common stock, par value $0.01 per share, at an initial price to the public of $23.35, including 866,250 shares of common stock sold pursuant to the full exercise of an option to purchase additional shares of common stock granted to the underwriters, resulting in approximately $149.0 million in net proceeds, after deducting the underwriting discount and offering expenses. The Company used the proceeds from the offering to repay a portion of the outstanding borrowings on its Revolving Facility, which had been used to fund a portion of the purchase price of acquisitions in the second quarter of 2019.
At-The-Market Offering—On March 4, 2019, the Company entered into a new equity distribution agreement to issue and sell, from time to time, up to $300.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “New ATM Program”). In connection with the entry into the equity distribution agreement and the commencement of the New ATM Program, the Company’s “at-the-market” equity offering program pursuant to the Company’s prior equity distribution agreement, dated as of May 17, 2017, was terminated (the “Prior ATM Program”).

There was no New ATM Program activity for the three and six months ended June 30, 2019. The following table summarizes the Prior ATM Program activity for 2019 (in thousands, except per share amounts):
 
For the Three Months Ended
 
March 31, 2019
Number of shares
2,459

Average sales price per share
$
19.48

Gross proceeds*
$
47,893

*Total gross proceeds is before $0.6 million of commissions paid to the sales agents during the three months ended March 31, 2019 under the Prior ATM Program.

As of June 30, 2019, the Company had $300.0 million available for future issuances under the New ATM Program.

Dividends on Common StockThe following table summarizes the cash dividends on the Company’s common stock declared by the Company’s Board of Directors for the first six months of 2019 (dollars in thousands, except per share amounts):
 
For the Three Months Ended
 
March 31, 2019
June 30, 2019
Dividends declared per share
$
0.225

$
0.225

Dividends payment date
April 15, 2019

July 15, 2019

Dividends payable as of record date
$
20,012

$
21,508

Dividends record date
March 29, 2019

June 28, 2019




8. STOCK-BASED COMPENSATION
All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company.
Restricted Stock Awards— In connection with the separation of Ensign’s healthcare business and its real estate business into two separate and independently publicly traded companies (the “Spin-Off”), employees of Ensign who had unvested shares of restricted stock were given one share of CareTrust REIT unvested restricted stock totaling 207,580 shares at the Spin-Off. These restricted shares are subject to a time vesting provision only and the Company does not recognize any stock

15

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


compensation expense associated with these awards. As of June 30, 2019, there were 1,760 unvested restricted stock awards outstanding that were issued in connection with the Spin-Off.
In February 2019, the Compensation Committee of the Company’s Board of Directors granted 91,440 shares of restricted stock to officers and employees. Each share had a fair market value on the date of grant of $22.00 per share, based on the closing market price of the Company’s common stock on that date, and the shares vest in four equal annual installments beginning on the first anniversary of the grant date. Additionally, in February 2019, the Compensation Committee granted 71,440 performance stock awards to officers. Each share had a fair market value on the date of grant of $22.00 per share, based on the closing market price of the Company’s common stock on that date. Performance stock awards are subject to both time and performance based conditions and vest over a one- to four-year period. The amount of performance awards that will ultimately vest is dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding fiscal year over year growth of 5.0% or greater.
In May 2019, the Compensation Committee of the Company's Board of Directors granted 17,749 shares of restricted stock to members of the Board of Directors. Each share had a fair market value on the date of grant of $24.23 per share, based on the closing market price of the Company's common stock on that date, and the shares vest in full on the earlier to occur of April 30, 2020 or the Company’s 2020 Annual Meeting of Stockholders.
The following table summarizes the stock-based compensation expense recognized (dollars in thousands):
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Stock-based compensation expense
$
1,147

 
$
924

 
$
2,141

 
$
1,828


As of June 30, 2019, there was $6.2 million of unamortized stock-based compensation expense related to unvested awards and the weighted-average remaining vesting period of such awards was 2.3 years. 

9. EARNINGS PER COMMON SHARE
The following table presents the calculation of basic and diluted EPS for the Company’s common stock for the three and six months ended June 30, 2019 and 2018, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS (amounts in thousands, except per share amounts):
 
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Numerator:
 
 
 
 
 
 
 
Net income
$
19,698

 
$
13,267

 
$
35,751

 
$
27,874

Less: Net income allocated to participating securities
(79
)
 
(96
)
 
(165
)
 
(198
)
Numerator for basic and diluted earnings available to common stockholders
$
19,619

 
$
13,171

 
$
35,586

 
$
27,676

Denominator:
 
 
 
 
 
 
 
Weighted-average basic common shares outstanding
94,036

 
76,374

 
91,039

 
75,941

Weighted-average diluted common shares outstanding
94,036

 
76,374

 
91,039

 
75,941

 
 
 
 
 
 
 
 
Earnings per common share, basic
$
0.21

 
$
0.17

 
$
0.39

 
$
0.36

Earnings per common share, diluted
$
0.21

 
$
0.17

 
$
0.39

 
$
0.36


The Company’s unvested restricted shares associated with its incentive award plan and unvested restricted shares issued to employees of Ensign at the Spin-Off have been excluded from the above calculation of earnings per diluted share for the three and six months ended June 30, 2019 and 2018, when their inclusion would have been anti-dilutive.

16

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)



10. COMMITMENTS AND CONTINGENCIES
The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, which are not individually or in the aggregate anticipated to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. Claims and lawsuits may include matters involving general or professional liability asserted against the Company’s tenants, which are the responsibility of the Company’s tenants and for which the Company is entitled to be indemnified by its tenants under the insurance and indemnification provisions in the applicable leases.

11. CONCENTRATION OF RISK
Major operator concentrations – As of June 30, 2019, Ensign leased 93 skilled nursing, multi-service campuses, assisted living and independent living facilities which had a total of 9,923 operational beds and are located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Texas, Utah and Washington. The four states in which Ensign leases the highest concentration of properties are California, Texas, Utah and Arizona. During the three and six months ended June 30, 2019, Ensign represented 34% and 37%, respectively, of the Company’s rental income, exclusive of operating expense reimbursements. During each of the three and six months ended June 30, 2018, Ensign represented 42% of the Company’s rental income, exclusive of operating expense reimbursements.
Ensign is subject to the registration and reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s financial statements, as filed with the SEC, can be found at http://www.sec.gov. The Company has not verified this information through an independent investigation or otherwise.
 


17

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


12. SUMMARIZED CONDENSED CONSOLIDATING INFORMATION
The Notes issued by the Operating Partnership and CareTrust Capital Corp. on May 10, 2017 are jointly and severally, fully and unconditionally, guaranteed by CareTrust REIT, Inc., as the parent guarantor (the “Parent Guarantor”), and the wholly owned subsidiaries of the Parent Guarantor other than the Issuers (collectively, the “Subsidiary Guarantors” and, together with the Parent Guarantor, the “Guarantors”), subject to automatic release under certain customary circumstances, including if the Subsidiary Guarantor is sold or sells all or substantially all of its assets, the Subsidiary Guarantor is designated “unrestricted” for covenant purposes under the indenture governing the Notes, the Subsidiary Guarantor’s guarantee of other indebtedness which resulted in the creation of the guarantee of the Notes is terminated or released, or the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied.
The following provides information regarding the entity structure of the Parent Guarantor, the Issuers and the Subsidiary Guarantors:
CareTrust REIT, Inc. – The Parent Guarantor was formed on October 29, 2013 in anticipation of the separation of Ensign’s healthcare business and its real estate business into two separate and independently publicly traded companies (the “Spin-Off”) and was a wholly owned subsidiary of Ensign prior to the effective date of the Spin-Off on June 1, 2014. The Parent Guarantor did not conduct any operations or have any business prior to the date of the consummation of the Spin-Off related transactions.
CTR Partnership, L.P. and CareTrust Capital Corp. – The Issuers, each of which is a wholly owned subsidiary of the Parent Guarantor, were formed on May 8, 2014 and May 9, 2014, respectively, in anticipation of the Spin-Off and the related transactions. The Issuers did not conduct any operations or have any business prior to the date of the consummation of the Spin-Off related transactions.
Subsidiary Guarantors – The Subsidiary Guarantors consist of all of the subsidiaries of the Parent Guarantor other than the Issuers.

Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is provided for the Parent Guarantor, the Issuers, and the Subsidiary Guarantors. There are no subsidiaries of the Company other than the Issuers and the Subsidiary Guarantors. This summarized financial information has been prepared from the financial statements of the Company and the books and records maintained by the Company.

18

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)



CONDENSED CONSOLIDATING BALANCE SHEETS
JUNE 30, 2019
(in thousands, except share and per share amounts)
 
Parent
Guarantor
 
Issuers
 
Combined
Subsidiary
Guarantors
 
Elimination
 
Consolidated
Assets:
 
 
 
 
 
 
 
 
 
Real estate investments, net
$

 
$
951,636

 
$
530,404

 
$

 
$
1,482,040

Other real estate investments, net

 
23,646

 
3,079

 

 
26,725

Cash and cash equivalents

 
2,629

 

 

 
2,629

Accounts and other receivables, net

 
9,691

 
14

 

 
9,705

Prepaid expenses and other assets

 
6,942

 
5

 

 
6,947

Deferred financing costs, net

 
3,513

 

 

 
3,513

Investment in subsidiaries
979,754

 
510,129

 

 
(1,489,883
)
 

Intercompany

 
22,720

 

 
(22,720
)
 

Total assets
$
979,754

 
$
1,530,906

 
$
533,502

 
$
(1,512,603
)
 
$
1,531,559

Liabilities and Equity:
 
 
 
 
 
 
 
 
 
Senior unsecured notes payable, net
$

 
$
295,532

 
$

 
$

 
$
295,532

Senior unsecured term loan, net

 
198,608

 

 

 
198,608

Unsecured revolving credit facility

 
45,000

 

 

 
45,000

Accounts payable and accrued liabilities

 
12,012

 
653

 

 
12,665

Dividends payable
21,617

 

 

 

 
21,617

Intercompany

 

 
22,720

 
(22,720
)
 

Total liabilities
21,617

 
551,152

 
23,373

 
(22,720
)
 
573,422

Equity:
 
 
 
 
 
 
 
 
 
Common stock, $0.01 par value; 500,000,000 shares authorized, 95,073,223 shares issued and outstanding as of June 30, 2019
951

 

 

 

 
951

Additional paid-in capital
1,161,144

 
817,519

 
321,761

 
(1,139,280
)
 
1,161,144

Cumulative distributions in excess of earnings
(203,958
)
 
162,235

 
188,368

 
(350,603
)
 
(203,958
)
Total equity
958,137

 
979,754

 
510,129

 
(1,489,883
)
 
958,137

Total liabilities and equity
$
979,754

 
$
1,530,906

 
$
533,502

 
$
(1,512,603
)
 
$
1,531,559


19

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


CONDENSED CONSOLIDATING BALANCE SHEETS
DECEMBER 31, 2018
(in thousands, except share and per share amounts)
 
Parent
Guarantor
 
Issuers
 
Combined
Subsidiary
Guarantors
 
Elimination
 
Consolidated
Assets:
 
 
 
 
 
 
 
 
 
Real estate investments, net
$

 
$
887,921

 
$
328,316

 
$

 
$
1,216,237

Other real estate investments, net

 
12,299

 
5,746

 

 
18,045

Cash and cash equivalents

 
36,792

 

 

 
36,792

Accounts and other receivables, net

 
9,359

 
2,028

 

 
11,387

Prepaid expenses and other assets

 
8,666

 
2

 

 
8,668

Deferred financing costs, net

 
633